logo-loader
viewPhysiomics PLC

Physiomics zips higher with trading ahead of expectations

The AIM-quoted firm expects revenues to almost double from last year, while losses should be “materially” lower than current market forecasts

doctors looking at x-ray
Physiomics’ technology can predict what effect a drug might have on a tumour

Physiomics Plc (LON:PYC) surged at the opening bell on Thursday after telling investors it is trading ahead of expectations as it approaches the end of its year.

The company, whose technology can predict the effect a drug might have on a cancer, expects full-year income to be greater than £495,000 – almost double the £270,500 it generated in 2017.

READ: Physiomics ready to build on Merck Serono landmark

A multi-year, £440,000 contract signed with German Firm Merck KgaA (not that Merck) back in November has been key to the outperformance.

The growth will translate into a healthier bottom line as well, with Physiomics adding that losses should be “materially” lower than current forecasts.

“We are pleased that as a result of the hard work of the team, the company continues to show progress not only in attracting new clients but in translating this into bookable revenue which is moving us closer to profitability,” said chief executive Jim Millen.

Shares zipped 11% higher to 4.7p in early deals in London.

Quick facts: Physiomics PLC

Price: 2.68 GBX

AIM:PYC
Market: AIM
Market Cap: £1.93 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Southern Gold active on the ground in South Korea with multiple rigs and...

Southern Gold Limited's (ASX:SAU) managing director Simon Mitchell tells Proactive London's Andrew Scott they're looking to become recognised as the go-to name for exploration in South Korea.  ''We're now 100% focused on South Korea and I think that's been well received by the market to...

1 hour, 56 minutes ago

2 min read